Jakowlew Sonia B
National Cancer Institute, Cell and Cancer Biology Branch, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA.
Cancer Metastasis Rev. 2006 Sep;25(3):435-57. doi: 10.1007/s10555-006-9006-2.
Transforming growth factor-beta (TGF-beta) is a multifunctional regulatory polypeptide that is the prototypical member of a large family of cytokines that controls many aspects of cellular function, including cellular proliferation, differentiation, migration, apoptosis, adhesion, angiogenesis, immune surveillance, and survival. The actions of TGF-beta are dependent on several factors including cell type, growth conditions, and the presence of other polypeptide growth factors. One of the biological effects of TGF-beta is the inhibition of proliferation of most normal epithelial cells using an autocrine mechanism of action, and this suggests a tumor suppressor role for TGF-beta. Loss of autocrine TGF-beta activity and/or responsiveness to exogenous TGF-beta appears to provide some epithelial cells with a growth advantage leading to malignant progression. This suggests a pro-oncogenic role for TGF-beta in addition to its tumor suppressor role. During the early phase of epithelial tumorigenesis, TGF-beta inhibits primary tumor development and growth by inducing cell cycle arrest and apoptosis. In late stages of tumor progression when tumor cells become resistant to growth inhibition by TGF-beta due to inactivation of the TGF-beta signaling pathway or aberrant regulation of the cell cycle, the role of TGF-beta becomes one of tumor promotion. Resistance to TGF-beta-mediated inhibition of proliferation is frequently observed in multiple human cancers, as are various alterations in the complex TGF-beta signaling and cell cycle pathways. TGF-beta can exert effects on tumor and stromal cells as well as alter the responsiveness of tumor cells to TGF-beta to stimulate invasion, angiogenesis, and metastasis, and to inhibit immune surveillance. Because of the dual role of TGF-beta as a tumor suppressor and pro-oncogenic factor, members of the TGF-beta signaling pathway are being considered as predictive biomarkers for progressive tumorigenesis, as well as molecular targets for prevention and treatment of cancer and metastasis.
转化生长因子-β(TGF-β)是一种多功能调节多肽,是一大类细胞因子的典型成员,这类细胞因子控制细胞功能的许多方面,包括细胞增殖、分化、迁移、凋亡、黏附、血管生成、免疫监视和存活。TGF-β的作用取决于多种因素,包括细胞类型、生长条件以及其他多肽生长因子的存在。TGF-β的生物学效应之一是利用自分泌作用机制抑制大多数正常上皮细胞的增殖,这表明TGF-β具有肿瘤抑制作用。自分泌TGF-β活性丧失和/或对外源性TGF-β的反应性丧失似乎为一些上皮细胞提供了生长优势,导致恶性进展。这表明TGF-β除了具有肿瘤抑制作用外,还具有促癌作用。在上皮肿瘤发生的早期阶段,TGF-β通过诱导细胞周期停滞和凋亡来抑制原发性肿瘤的发生和生长。在肿瘤进展的后期,当肿瘤细胞由于TGF-β信号通路失活或细胞周期异常调节而对TGF-β介导的生长抑制产生抗性时,TGF-β的作用就变成了肿瘤促进作用。在多种人类癌症中经常观察到对TGF-β介导的增殖抑制的抗性,复杂的TGF-β信号通路和细胞周期通路也存在各种改变。TGF-β可对肿瘤细胞和基质细胞产生影响,并改变肿瘤细胞对TGF-β的反应性,以刺激侵袭、血管生成和转移,并抑制免疫监视。由于TGF-β作为肿瘤抑制因子和促癌因子的双重作用,TGF-β信号通路的成员正被视为进行性肿瘤发生的预测生物标志物,以及癌症和转移预防与治疗的分子靶点。